Major cancer trial questions need for surgery
NCT ID NCT00930033
Summary
This study aimed to find out if patients with kidney cancer that has spread (metastasized) live longer by having their kidney removed first, followed by the drug sunitinib, compared to just taking the drug alone. It involved 452 adults with a specific type of advanced kidney cancer. The goal was to see if the major surgery provides a meaningful survival benefit when combined with modern targeted drug therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Necker
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.